Design bioactive patches tailored to your specs—ensuring regulatory compliance and market fit.
Customization is key in drug delivery. We collaborate closely with partners to understand their unique requirements and needs, be it targeting specific conditions or enhancing wellness. Our team crafts tailored solutions that exceed expectations, catering to diverse market demands.
ZHI Technologies offers a service aimed at assisting companies in broadening their brand presence and accessing new markets. Through collaboration and leveraging cutting-edge technology, we provide support in diversifying product portfolios and exploring untapped market opportunities. This service is designed to facilitate growth and expansion for our partners, without adopting a sales-oriented approach.
Time is of the essence in the competitive market. Our streamlined development process ensures swift and cost-efficient product launches, from concept to manufacturing. With our support, partners can seize market opportunities promptly and effectively.
Our turnkey solutions ensure full compliance with local standards, from product registration to quality assurance. Trust our experts to guide you through the regulatory maze seamlessly.
Behind ZHI Technologies lies a team of seasoned professionals, experts in pharmacology, clinical testing, chemistry, and product development. With years of experience in transdermal delivery, we offer partners unparalleled guidance and insights.
ZHI’s commitment to excellence is backed by rigorous clinical research. Studies on their Cannabidiol (CBD) transdermal patches have demonstrated excellent adhesion, minimal skin irritation, and precise dosage delivery over a 24-hour period. In fact, ZHI’s proprietary patch formulation has shown a bioavailability of over 75%, significantly outperforming traditional literature data for transdermal CBD delivery.
ZHI Technologies does not just offer innovative products; they also provide a full range of services to qualified companies looking to harness the power of transdermal delivery. From product development and manufacturing to regulatory compliance and market expansion, ZHI’s private-label partnerships offer a pathway to new revenue streams and enhanced patient care.
Reliable Adhesion, Lasting Relief:
ZHI’s patches stick securely for 24-hour comfort.
Consistent Delivery, Day and Night
Our patches provide steady drug delivery round-the-clock.
On-Demand Control, Instant Adjustment:
Patients can stop or adjust dosing anytime for instant relief.
Steady Drug Levels, Predictable Results:
Maintaining consistent drug levels ensures reliable outcomes.
Precise Dosage, Tailored Treatment:
Our patches offer precise dosing for personalized care.

ZHI Patented Technologies is strategically positioned to revolutionize the transdermal patch market with its innovative approach to product distribution, white labeling services, and R&D collaborations. By leveraging consignment channels, in-house sales teams, and white labeling opportunities, we ensure widespread access to our cutting-edge transdermal patches.
Utilizing consignment via rack jobbers and an in-house salesforce, we ensure widespread distribution of our transdermal patches.
Offering white labeling services enables partners to leverage our innovative products under their own brand, expanding market reach.
Catering to pharmaceutical companies, we provide small-batch R&D services, fostering collaboration and innovation in drug development.
Disclaimer
The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act require this notice.
Copyright © 2026 | ZHI Technologies